Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate Finance Medicare Reform Hearings To Begin In February

Executive Summary

The Senate Finance Committee expects to hold hearings in early- to mid-February to address the need for Medicare reform legislation, including the addition of a prescription drug benefit.

You may also be interested in...



PhRMA Plan For Rx-Only Medicare Bill Calls For Independence From HCFA

The White House may be willing to support a Medicare drug benefit that is overseen by an agency other than the Health Care Financing Administration, Pharmaceutical Research & Manufacturers of America President Alan Holmer maintained.

PhRMA Plan For Rx-Only Medicare Bill Calls For Independence From HCFA

The White House may be willing to support a Medicare drug benefit that is overseen by an agency other than the Health Care Financing Administration, Pharmaceutical Research & Manufacturers of America President Alan Holmer maintained.

PhRMA Moves To Head Off Clinton Assault; Considers Incremental Rx Benefit

The Pharmaceutical Research & Manufacturers of America is attempting to defuse some of the Clinton Administration's rhetoric on drug costs to the elderly ahead of the State of the Union address.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS035457

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel